TULANE TALK

January 4, 2007

Good Morning:

After consultation with the School of Medicine and Health Sciences Center leadership, I am pleased to announce the appointments of Lee Hamm as interim dean of the School of Medicine and Alan Miller as interim senior vice president for the Health Sciences Center. Both appointments are effective February 1, 2007.

Lee and Alan are both trusted colleagues who have made many contributions to Tulane. Lee came to Tulane in 1992. He is currently chair of the Department of Internal Medicine and co-director of the Tulane Hypertension and Renal Center of Excellence. His research in cardiovascular disease, kidney disease, the genetic causes of acid-based disorders and other areas has been funded by the American Heart Association, the National Institutes of Health and the Veterans Administration. As a member of the medical school faculty, Lee has served as a university senator and as chair of the General Medical Faculty.

In recent months Lee has been heavily involved in helping to re-establish medical care in New Orleans in the wake of Katrina. He led a clinical strategic planning committee that proposed new directions for Tulane’s clinical mission and he recently became the chair of the Tulane University Medical Group board, which oversees the Tulane faculty clinical practice.

Alan, who is currently the associate senior vice president for the Health Sciences Center, came to Tulane in 1993 to establish a bone marrow and stem cell transplant program and to assist in establishing the Tulane Cancer Center. He is also the principal investigator of Tulane’s Southwest Oncology Group, which conducts cutting-edge cancer research. In addition, Alan is principal investigator of several trials dealing with bone marrow and stem cell transplant for leukemia, bone marrow failure and lymphoma. Alan also had a leading role in re-establishing our health sciences operations after Katrina.

Alan’s leadership in health care goes beyond his responsibilities within the university. He is vice chairman of both the Louisiana Health Care Commission and the New Orleans BioInnovation Center, which is developing a downtown biotechnology center that will produce adult stem cells and other medical marvels to fight disease. Alan also serves as a primary liaison in Tulane’s partnerships with LSU in the areas of gene therapy and cancer.

In his role as interim senior vice president, Alan will have responsibility for all areas currently ascribed to the senior vice president for the Health Sciences Center, with the exception of the School of Medicine (including the Tulane University Medical Group and HCA partnership), which will report directly to me during this interim period.

I hope you will join me in congratulating and thanking Lee and Alan for assuming these interim positions. Their continued dedication and commitment to the university are greatly valued and appreciated.